Multi-institutional Prospective Registry in Pulmonary Hypertension associated with Respiratory Disease

Conditions

Pulmonary Hypertension Associated with Respiratory Disease

Tanabe N, Kumamaru H, Tamura Y, Kondoh Y, Nakayama K, Kinukawa N, Kimura T, Nishiyama O, Tsujino I, Shigeta A, Morio Y, Inoue Y, Kuraishi H, Hirata KI, Tanaka K, Kuwana M, Nagaoka T, Handa T, Sugimura K, Sakamaki F, Naito A, Taniguchi Y, Matsubara H, Hanaoka M, Inami T, Hayama N, Nishimura Y, Kimura H, Miyata H, Tatsumi K, JRPHS Group.

2024-03-263 citations

10.1016/j.jacasi.2024.01.009

The Effects of Pulmonary Vasodilating Agents on Right Ventricular Parameters in Severe Group 3 Pulmonary Hypertension: A Pilot Study

Takahiro Sato, Ichizo Tsujino, Ayako Sugimoto, Toshitaka Nakaya, Taku Watanabe et al. (10 authors)

Pulmonary Circulation2016-08-019 citations

10.1086/688712

Interventions

None listed

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: Patients >=18 years old with PH including borderline PH (mean pulmonary arterial pressure 20-25mmHg) associated with respiratory disease by right heart catheterization

Exclusion criteria

Exclusion criteria: Patients who refused this study Under 18 years old

Design outcomes

Primary

Measure	Time frame
Lung transplantation Worsening of NHYA, Addition of PAH specific drugs, Hospitalization due to PH Prevalence of progression from borderline PH	—

Secondary

Measure	Time frame
Liver dysfunction Edema Adverse effects of drugs Pregnancy Hospitalization due to infection and respiratory failure Mechanical ventilation	—

Countries

Japan

Contacts

Public ContactNobuhiro Tanabe

Graduate School of Medicine, Chiba University Department of Respirology

ntanabe@faculty.chiba-u.jp043-222-7171

Outcome results